Skip to main content
UKPMC Funders Author Manuscripts logoLink to UKPMC Funders Author Manuscripts
. Author manuscript; available in PMC: 2025 Mar 19.
Published in final edited form as: Lancet Digit Health. 2025 Mar 1;7(3):e172–e174. doi: 10.1016/j.landig.2025.01.002

Passive sensing at scale to advance the understanding of mental health

Aiden Doherty 1,, Sandra Bucci 2, Alexandra Kenny 3, Roman Kotov 4, Gosia Lipinska 5, Laura Ospina-Pinillos 6, Katharina Schultebraucks 7
PMCID: PMC7617507  EMSID: EMS202199  PMID: 40015762

Introduction

Passive sensing devices such as smartphones and wearables provide a major opportunity to transform our understanding of the mechanisms, determinants, and consequences of mental health problems, including anxiety, depression, and psychosis. Most people in high- and low-income societies now own and regularly use passive sensing devices, where almost 70% of the world’s total population now uses a mobile device1. For example, despite limited resources, over 70% of the South African population use a smartphone2, while one-fifth of US adults own wearable technologies, like smartwatches and fitness trackers.1 These devices typically have a range of embedded sensors, such as accelerometers, that offer the potential to continuously, noninvasively, and painlessly measure traits that are relevant to mental health such as physical activity, sleep, and circadian rhythms. If harnessed effectively, this high level of health-relevant data would advance understanding and early intervention for mental health problems and lower the barriers for researchers and clinicians to start or continue using digital technologies for mental health. However, given the complexity of mental health measurement, it is important to address some key challenges so that data from smartphones and wearables can reliably inform the future care of people living with mental health difficulties.

Value Proposition

Smartphones and wearables offer the opportunity to improve how we understand, predict, prevent, detect, and treat mental health problems. For example, an important element of depression diagnosis and monitoring is to consider symptoms self-reported by patients. In contrast, passive sensing devices offer the potential to identify people who encounter changes in their activity levels, sleep pattern and daily movements just before they become unwell or experience a relapse. The wide range of data from these devices could provide a much clearer picture of the daily rhythms of health and well-being, as well as the environment in which these occur. The touch screens, motion sensors, microphones, cameras, location sensors, and other technologies within these devices allow us to rethink how we measure things that might be important and relevant to mental health research. For risk factors such as physical activity, wrist-worn devices offer an opportunity to shift from the use of subjective questionnaires to the continuous objective measurement of physical activity patterns. The use of passive sensors could clearly improve the granularity, validity, reliability, and collection of some data relevant to mental health.

Problem Statement

However, the current evidence base is not sufficiently mature to support the use of symptoms measured from smartphones and wearables to reliably inform the care of people living with mental health problems. Flagship studies such as AURORA2 or CONNECT3 will provide valuable new evidence in clinical populations. Nevertheless, to mitigate against bias arising from underpowered case-control studies, smartphones and wearables have not been used for mental health research at the scale of tens or hundreds of thousands of participants in prospective longitudinal studies in populations with a high burden of mental health difficulties. Although the UK Biobank is one of the most important medical resources worldwide3 and contains a wearable assessment of physical activity and sleep in 100,000 participants4; the study population (median age at baseline of 62 years, IQR 54–68 years) is not ideal to examine the causes of mental health problems. This is because it can only look at mental health in the older population, where depression and Alzheimer’s can occur, and it is important to note that 75% of mental health problems start before the age of 24 years5.

Beyond study design issues, there also exists a lack of agreed technical standards and associated training on how to measure relevant traits from passive sensor data

For example, in the field of physical activity, there are numerous proposed methods6, sensors, metrics, and little consensus on how to record a simple measurement such as daily step count. It is also recognised that analytic decisions such as the temporal resolution selected for summarising and analysing sensor data will affect how results are interpreted7. In addition, it is difficult to maintain research analysis pipelines due to frequent software updates from manufacturers of consumer wearables. Furthermore, passive sensors such as optical photoplethysmogram sensors might introduce bias where light is absorbed differently, and hence the algorithm output might be less accurate, in patients with darker skin tones versus those with light skin tones. Research capacity to address these important issues is currently limited due to a lack of relevant health data science and technical skills within mental health study teams.

Finally, ethical and privacy challenges exist for passive sensors such as Bluetooth and global positioning sensors that are good to infer social connectiveness and mobility respectively but in both cases might reveal unwanted data on who someone met or where they went. It is important to address these major challenges for smartphones and wearables to move beyond promise and towards delivery of new insights and more responsive care for the wider mental health community.

Recommendations For Passive Sensing In Mental Health Research

In September 2023, Wellcome and Google partnered to host a convening of a diverse set of clinicians, biomedical and computer scientists, funding agencies, and lived experience experts to identify recommendations to advance the use of passive sensing in mental health research.

Establish a biobank of passive sensors in populations with the highest burden of mental health problems

Studies such as the UK Biobank, All of Us8, and China Kadoorie Biobank9, provide the template and impetus for a resource of a similar scale in populations at high risk of mental health difficulties (such as adolescents and younger adults) to help transform our understanding of the causes and consequences, prevention, and treatment of mental health problems. These studies have included passive sensing measurements in tens and hundreds of thousands of participants, with linkage to subsequent diagnoses of ill health. Furthermore, they offer a mechanism to promote innovative science by maximising global access to the data in an equitable and transparent manner. A new study would need careful consideration of target populations of interest, which should be determined in consultation with multiple stakeholders globally. An important requirement will be linkage to clinical patient notes, and validated questionnaires (that could be collected via a smartphone platform). The establishment of this biobank, or enhancement of relevant existing biobanks, would revolutionise our ability to evaluate the effectiveness of passive sensing data in prognosticating mental health risk and inform future strategies to develop new interventions.

Build large-scale validation datasets to support an industry-academia consortium around the analysis of passive sensor data

Ready access to such a large-scale biobank for mental health research, with passive sensor measurements, would coalesce researchers from many disciplines across academia and industry to collaborate to ensure that different types of complex passive sensor data are appropriately analysed. To this end, collaboration between researchers and industry, to achieve cross-platform metrics for previously identified variables of interest, such as sleep quantity, quality and regularity (e.g. point of sleep onset, wake after sleep onset) and physical activity (step count, heart rate) would allow for reliable interpretation of large data sets that are pooled from multiple studies, to infer robust prediction, detection and treatment of mental health conditions. To achieve this, it is important to design a range of supporting validation datasets with reference measurements such as polysomnography for sleep, or camera footage of steps for physical activity. In addition, the creation of new public-private partnerships could provide a forum to provide advance notice of software updates, which have been disruptive, or fatal, to past research projects. If a series of collaborative validation studies are successfully implemented, this initiative would provide much more clarity to researchers and clinicians around how to preprocess, analyse, and interpret multiple modalities of passive sensing data.

Design ecosystems to encourage ethical use of passive sensors in health research

Passive sensors such as GPS are likely to offer important new measurements but also have associated privacy trade-offs. It is therefore important to bring together humanities researchers to lead the debate on the ethical requirements for scientific research and technological innovation, capable of commanding well-founded public trust and confidence. Such a process will need to be co-designed and co-developed with Lived Experience experts from different cultures and locations to ensure equity. This includes addressing inequities in accessing mental health support and digital technology (e.g., in lower resource settings, not settling for “poor tech for poor people”). The need to include groups currently under-represented in mental health research remains a key consideration. Technology navigators will be important in helping some groups of patients move through the complex care continuum and technology, with the goal of facilitating information flow and resource accessibility for research and clinical outcomes. In addition, the input of Lived Experience, and other relevant, experts will be important to co-create safe and effective data access procedures to any new research studies created. This would help identify solutions to ensure safe data access to approved researchers and clinicians, somewhat similar to procedures used by the CVD-COVID-UK consortium to provide researcher access to relevant NHS England data10.

Conclusions

Smartphones and wearables offer the opportunity to improve how we predict, prevent, detect, and treat mental health problems. However, large scale biobanks containing these measurements in a standardized way in populations with high burdens of mental health difficulties are needed. Supported by diverse validation datasets to address device heterogeneity and an ecosystem of ethical guidance, we can then reliably determine if passive sensing can inform the future care of people living with mental health problems.

Acknowledgements

Wellcome and Google partnered to host a workshop in New York, USA to identify recommendations to advance the use of technology in mental health research. We would like to acknowledge ideas and input received during the workshop from: Megan Jones Bell, Monica Bharel, Miguel Diaz, Matthew Thompson, Renee Schneider, Isaac Galatzer-Levy (all Google), Miranda Wolpert, Lynsey Bilsland, Elena Netsi, Matthew Brown, Gwydion Williams, and Christopher Christofi (all Wellcome). The funders had no active role in the conceptualisation or writing of this report.

For the purpose of open access, the author(s) has applied a Creative Commons Attribution (CC BY) licence to any Author Accepted Manuscript version arising.

Footnotes

Declaration of interest

AD’s research team is supported by grants from the Wellcome Trust [223100/Z/21/Z, 227093/Z/23/Z], Novo Nordisk, Swiss Re, Boehringer Ingelheim, the British Heart Foundation Centre of Research Excellence (grant number RE/18/3/34214), and Health Data Research UK, an initiative funded by UK Research and Innovation, Department of Health and Social Care (England) and the devolved administrations, and leading medical research charities. AD’s research group has also received research funding and software license royalties from GlaxoSmithKline (GSK). In addition, AD reports donations to purchase equipment from Swiss Re; honoraria as a grant panel member for the Wellcome Trust, UKRI and NIHR; personal payments from Harvard University (NIH grant), University of Wisconsin (NIH grant), and the Wellcome Trust; honoraria from the American Academy of Insurance Medicine and for thesis examinations; support to attend the 2024 International consensus meeting on mobility measurement (Toronto), the 2023 Big Model AI for Drug Design workshop (Abu Dhabi), the 2020 3rd NYU Biomedical and Biosystems Conference (Abu Dhabi), the 2020 Academy of Medical Sciences, UK-Japan Symposium on Data-Driven Health, the 2019 SLEEP Meeting (USA), and the 2017 Hong Kong Academy of Medicine Annual Scientific Meeting; and being on Scientific Advisory Boards for the EU iPROLEPSIS project on psoriatic arthritis inflammation and the EU IMI IDEA-FAST project on wearable sensors in neurodegenerative trials. SB is supported by a National Institute for Health and Care Research research professorship [NIHR300794] and the Manchester Biomedical Research Centre [NIHR 203308]. SB’s research group has also received funding from the Wellcome Trust. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. In addition, SB is Chair of a Wellcome Trust fellowship committee and receives and honorarium for this. SB also reports honoraria for ad hoc workshops; royalties on an edited book; speaker honorarium from Boehringer Ingelheim; honorarium as Editor of a peer-reviewed journal; honoraria for thesis examinations; support for symposia or plenary addressees at conferences; being a member of a Trial Steering Committee for a Wellcome Trust funded project; being a member of a Trial Steering Committee for a Medical Research Council funded project; and being Director and shareholder of CareLoop Health Ltd. RK is supported by National Institute for Occupational Safety and Health [R21OH012614]. GL is supported by the Wellcome Trust [227115/Z/23/Z], has received honoraria for workshops, and has received funding support from the International Psychoanalytic Association. LOS has received research support from Foundation Botnar and Grand Challenges Canada. KS is supported by the National Institute of Mental Health [R01MH129856] and the National Heart, Lung, and Blood Institute [R01HL156134]. All authors received travel support from the Wellcome Trust to attend a workshop to identify the major issues and recommendations discussed in this manuscript.

Author contributions

All authors conceptualised this manuscript; AD wrote the original draft; SB, AK, RK, GL, LOP, and KS reviewed and edited the manuscript.

References

  • 1.Dixon WG, et al. Charting a Course for Smartphones and Wearables to Transform Population Health Research. J Med Internet Res. 2023;25:e42449. doi: 10.2196/42449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.McLean SA, et al. The AURORA Study: a longitudinal, multimodal library of brain biology and function after traumatic stress exposure. Molecular Psychiatry. 2020;25:283–296. doi: 10.1038/s41380-019-0581-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Allen NE, et al. Prospective study design and data analysis in UK Biobank. Science Translational Medicine. 2024;16:eadf4428. doi: 10.1126/scitranslmed.adf4428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Walmsley R, et al. Reallocation of time between device-measured movement behaviours and risk of incident cardiovascular disease. Br J Sports Med. 2021:bjsports-2021-104050. doi: 10.1136/bjsports-2021-104050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kessler RC, et al. Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry. 2005;62:593. doi: 10.1001/archpsyc.62.6.593. [DOI] [PubMed] [Google Scholar]
  • 6.Pulsford RM, et al. The impact of selected methodological factors on data collection outcomes in observational studies of device-measured physical behaviour in adults: A systematic review. International Journal of Behavioral Nutrition and Physical Activity. 2023;20:26. doi: 10.1186/s12966-022-01388-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Langener AM, et al. It’s All About Timing: Exploring Different Temporal Resolutions for Analyzing Digital-Phenotyping Data. Adv Methods Pract Psychol Sci. 2024;7:25152459231202676 [Google Scholar]
  • 8.Investigators, T. A. of U. R. P. The “All of Us” Research Program. New England Journal of Medicine. 2019;381:668–676. doi: 10.1056/NEJMsr1809937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Chen Z, et al. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol. 2011;40:1652–1666. doi: 10.1093/ije/dyr120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Knight R, et al. Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales. Circulation. 2022;146:892–906. doi: 10.1161/CIRCULATIONAHA.122.060785. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES